glp-1 with cv benefit Could receptor agonists improve long-term outcomes for patients peripheral artery disease? New research found that patients with #PAD and type 2 diabetes treated with GLP-1 therapy had lower rates of Comprehensive Overview of GLP-1 RAs

Der von Koeth et al

Results NOD mice manifest deficient responses to GLP-1 analogue exendin-4 GLP-1 and its analogues stimulate release of insulin from beta cells, which in turn allows uptake of glucose from the blood into tissues

Circulation 112 , I157I165 (2005)

Such a staged program would help determine not only whether a compound is protective, but also whether it acts by stabilizing an upstream contact-site defect, limiting secondary amplification, or merely delaying terminal bioenergetic failure

The FDA stated that compounders should use a 503A-compounded, low-concentration sterile vial and syringes that reflects the prescribed amount

Key Takeaway: Current human evidence suggests that for the vast majority of people, GLP-1 medications do not cause thyroid cancer